Variant report
Variant | nsv467239 |
---|---|
Chromosome Location | chr10:56897826-56905947 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555773680 | chr10:56901243-56901244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10825472 | chr10:56901246-56901247 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs7914330 | chr10:56901252-56901253 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs557982289 | chr10:56901305-56901306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191041718 | chr10:56901357-56901358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145252104 | chr10:56901360-56901361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563554936 | chr10:56901366-56901367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs58529830 | chr10:56901437-56901438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35454941 | chr10:56901541-56901542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542251479 | chr10:56901614-56901615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113971886 | chr10:56901620-56901621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs71504003 | chr10:56901621-56901622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs398096972 | chr10:56901630-56901631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7900671 | chr10:56901656-56901657 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs539610702 | chr10:56901702-56901703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs551420991 | chr10:56901724-56901725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182727876 | chr10:56901731-56901732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564654060 | chr10:56901775-56901776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76918264 | chr10:56901778-56901779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111704836 | chr10:56903200-56903201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574895054 | chr10:56903255-56903256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs115834026 | chr10:56903282-56903283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562185063 | chr10:56903322-56903323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560663111 | chr10:56903345-56903346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1936454 | chr10:56903361-56903362 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs201740002 | chr10:56903391-56903392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1936455 | chr10:56903450-56903451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs1936456 | chr10:56903458-56903459 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs188207798 | chr10:56903482-56903483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs367837439 | chr10:56903483-56903484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571623102 | chr10:56903498-56903499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530939978 | chr10:56903502-56903503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35401733 | chr10:56903514-56903515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374750677 | chr10:56903534-56903535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533318399 | chr10:56903537-56903538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1936457 | chr10:56903577-56903578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs5785116 | chr10:56903583-56903584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371608830 | chr10:56903584-56903585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536425273 | chr10:56903616-56903617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191896530 | chr10:56903663-56903664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150079391 | chr10:56903695-56903696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184036736 | chr10:56903718-56903719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200000604 | chr10:56903772-56903773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200787510 | chr10:56903776-56903777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111850733 | chr10:56903777-56903778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397971584 | chr10:56903784-56903785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373512493 | chr10:56903785-56903786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376407733 | chr10:56903786-56903787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374857660 | chr10:56903787-56903788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1444669 | chr10:56903794-56903795 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56901200-56901800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr10:56903200-56903800 | Enhancers | HMEC | breast |
3 | chr10:56903400-56904400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr10:56903400-56906400 | Enhancers | HUVEC | blood vessel |
5 | chr10:56903800-56904200 | Flanking Active TSS | HMEC | breast |
6 | chr10:56904000-56904400 | Enhancers | Hela-S3 | cervix |
7 | chr10:56904200-56905000 | Enhancers | HMEC | breast |
8 | chr10:56905000-56905600 | Weak transcription | HMEC | breast |
9 | chr10:56905600-56906400 | Enhancers | HMEC | breast |
10 | chr10:56905600-56906400 | Enhancers | NH-A | brain |
11 | chr10:56905800-56906600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |